Ultrasound Elastography
On this page
Direct answer
Elastography converts palpation into numbers: the harder a tissue, the more it resists deformation, and ultrasound can measure that resistance either qualitatively by strain (manual compression comparing lesion with surroundings) or quantitatively by shear-wave speed expressed in kilopascals or metres per second. Its clinical core is liver fibrosis staging — transient elastography values of roughly 7 kPa and above suggest significant fibrosis, and 12.5 to 14.5 kPa and above suggest cirrhosis — offering a biopsy-free follow-up for chronic hepatitis B, C and non-alcoholic fatty liver disease. In the thyroid and breast, stiffness raises suspicion of malignancy and is used to upgrade or downgrade lesions already seen on conventional ultrasound, not to replace fine-needle aspiration.
What you must remember
- Two families: strain elastography is qualitative and comparative (no absolute numbers); shear-wave elastography and transient elastography are quantitative (kPa or m/s), with stiffness rising with fibrosis and with many malignancies.
- Liver numbers to quote: transient elastography around 7 kPa and above for significant fibrosis (METAVIR F2 and beyond), roughly 9-10 kPa for severe fibrosis, and 12.5-14.5 kPa or more for cirrhosis; interpretation is per aetiology, not universal.
- Reliability criteria (transient elastography): at least 10 valid shots, success rate over 60 per cent, and interquartile range under 30 per cent of the median — otherwise the number is uninterpretable.
- Thyroid: papillary carcinoma is typically stiff; strain ratios and shear-wave values are adjuncts to TI-RADS, and elastography may spare some TI-RADS 3 nodules from immediate aspiration.
- Breast: the 5-point elastic score, where scores 4 and 5 (stiffer than surroundings, heterogeneously or entirely stiff) correlate with malignancy and can upgrade BI-RADS 3 and 4A lesions.
- Pitfalls that inflate stiffness: acute hepatitis and ALT flares, hepatic congestion from right heart failure, post-prandial state, cholestasis — all stiffen a liver without fibrosis.
- Failures: obesity with thick subcutaneous fat, narrow intercostal windows, and ascites defeat transient elastography in a meaningful minority of patients.
From numbers to decisions in the liver clinic
A 46-year-old with chronic hepatitis B and persistently normal ALT has a transient elastography reading of 6.2 kPa with an interquartile range of 0.4. That is no significant fibrosis, and the answer is surveillance ultrasound with alpha-fetoprotein rather than biopsy. A second patient, the same age with hepatitis C and an ALT three times normal, reads 11 kPa — but the inflammation itself stiffens the liver, so the number is interpreted with the ALT in view and repeated after the infection is treated. A third, with fatty liver disease, reads 19 kPa with splenomegaly of 15 cm and a platelet count of 95,000 — cirrhosis with portal hypertension, now entering variceal screening. FibroScan-style numbers thus act as triage: under 7, reassurance; 7-12.5, consider treatment intensity and follow-up; over 12.5, look for the complications of cirrhosis.
The same logic in a thyroid nodule: a TI-RADS 4 nodule that is soft on elastography may be watched, while a stiff one moves to fine-needle aspiration promptly — elastography shifts the threshold, it does not create the diagnosis.
Where students slip
The first slip is treating kPa as a biopsy replacement in all settings: elastography performs best for ruling out advanced fibrosis and worst for intermediate stages, where histology still arbitrates. The second is forgetting the confounders — a stiff reading in a patient with an ALT flare is inflammation, not cirrhosis, and the exam vignette deliberately supplies the raised ALT. The third is mixing up techniques: transient elastography (FibroScan) is a dedicated 1D method with no images, whereas shear-wave elastography is built into conventional scanners and shows the lesion — viva examiners ask precisely this difference. In the Indian context, elastography has become a practical answer to the enormous chronic hepatitis B and fatty liver burden where biopsy capacity is thin, and national guidance for viral hepatitis programmes embraces non-invasive markers first; quoting the 10-shot and 30 per cent interquartile-range quality criteria is what separates a pass answer from a distinction answer.
Frequently asked questions
How do strain and shear-wave elastography differ?
Strain elastography compares tissue deformation under manual compression and gives qualitative maps or ratios, while shear-wave elastography measures shear-wave speed and yields quantitative stiffness values in kPa or m/s.
What liver stiffness values suggest significant fibrosis and cirrhosis?
Values of about 7 kPa and above suggest significant fibrosis, and roughly 12.5-14.5 kPa and above suggest cirrhosis on transient elastography, interpreted alongside aetiology and ALT.
Which quality criteria make a transient elastography reading reliable?
At least 10 valid measurements with a success rate above 60 per cent and an interquartile range-to-median ratio below 30 per cent.
Which non-fibrotic conditions falsely raise liver stiffness?
Acute hepatitis with ALT flares, hepatic congestion from cardiac failure, cholestasis and recent food intake all stiffen the liver independent of fibrosis.
What elastography score suggests malignancy in a breast lump?
On the 5-point elastic score, scores of 4 and 5 — lesion stiffer than surrounding tissue, heterogeneously or entirely stiff — correlate with malignancy and support upgrading a BI-RADS 3 or 4A lesion to biopsy.